Abstract

Over the years, the production release of the plague vaccine is well developed its technology. The technological cycle of production of the preparation consists of regulated steps, however, despite their effectiveness it is necessary to modernize the manufactoring process, for example, solutions for some of the pressing needs of the customers, in particular, small groups of immunization. Our research has focused on obtaining experimental samples plague vaccine smaller compared to the commercial vaccine, the number of doses per vial prepared in a biomass production unit (ACM-Sh) surface by cultivation using all regulated processing steps, except step of combining content two swabs, and then an additional dilution of the cell suspension stabilizer. However, the time information and the subsequent preparation of such a vaccine is excluded us, since biomass is the second flush in quantitative terms is a ready raw material for the preparation of reduced dosage. The benefits of receiving the vaccine reduced the number of doses directly from the biomass of the second flush with the concentration of microbial cells Yersinia pestis EV 20–40 × 109 biotechnology greatly simplify the manufacture of such a preparation. The experimental vaccine series were tested by major regulated parameters: optical concentration, vitality, thermal stability, the loss on drying. In addition, the vaccine was prefabricated with high baseline viability to extreme temperatures (37±1)°C for 24 hours to exclude enough viable microbial cells for subsequent stabilization indicator of viability during storage. It should be noted that all the experimental samples preserved viability index not lower regulated (25%) during the experiment, in contrast to the commercial preparation. To determine the stability of the formulation during storage (over 3 years) was a comparative analysis of the viability of the experimental and commercial lots. To assess post vaccination immune analyzed the immune response to the introduction of a plague vaccine using FACSCalibur flow cytometer, considering that this technology has a high specificity, sensitivity and informativity. With regard to the immunogenic properties, the active component is recorded at a very high level as the white mice, and guinea pigs. Thus, the main biological indicators derived preparations (viability, thermal stability, storage stability) exceed those of commercial analog and provide effective immunological alterations and highly immunogenic in experimental animals.

Highlights

  • В комплексе иммунопрофилактических мероприятий уровень эффективности вакцинного препарата является определяющим

  • Что, в отличие от коммерческого препарата, все экспериментальные образцы сохранили показатель жизнеспособности не ниже регламентируемого (25%) на протяжении опыта

  • [Budika D.A., Abzaeva N.V., Ivanova G.F., Gostisheva S.E., Fisun A.A., Lyapustina L.V. Comparative analysis of experimental series of the vaccine plague live in terms of viability and thermal stability

Read more

Summary

Краткие сообщения

БИОТЕХНОЛОГИЯ СТАБИЛИЗАЦИИ ЖИВЫХ МИКРООРГАНИЗМОВ В БИОМАССЕ И В ПРЕПАРАТЕ ЧУМНОЙ ВАКЦИНЫ. Технологический цикл производства препарата состоит из регламентированных этапов, однако несмотря на их эффективность, возникает необходимость модернизации производственного процесса, например, для производста вакцины в небольших количествах. Однако сам момент сведения и последующего приготовления такой вакцины нами исключен, так как биомасса второго смыва в количественном отношении является готовым сырьем для препарата с уменьшенной дозировкой. Для выяснения стабильности препарата при хранении (в течение 3 лет) был проведен сравнительный анализ жизнеспособности экспериментальных и коммерческих серий. Для оценки поствакцинального иммунитета был проведен анализ иммунного ответа на введение чумной вакцины с помощью проточного цитометра FACSCalibur, учитывая, что эта технология обладает высокой специфичностью, чувствительностью и информативностью. Библиографическое описание: Будыка Д.А., Абзаева Н.В., Гостищева С.Е., Ракитина Е.Л., Иванова Г.Ф., Фисун А.А. Биотехнология стабилизации живых микроорганизмов в биомассе и в препарате чумной вакцины // Инфекция и иммунитет.

Материалы и методы
Результаты и обсуждение
Экспериментальная серия
Findings
Экспериментальная вакцина

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.